Entities / Company
Catalent (United Kingdom).
company in Swindon, United Kingdom
- Reports this week
- 0
- Active events
- 0
- Connections
- 6
What's happening
Gone quiet
No new reports in 90+ days-
Silexion Therapeutics Corp. pioneers RNAi therapies for KRAS-driven cancers, establishing partnerships with AMS and Catalent.Some support4 reports
-
The FDA accepted a revised approval submission regarding a Biohaven drug, while simultaneously canceling advisory committee discussions. This occurred amidst corporate restructuring, including Novo Holdings acquiring Catalent, which has a gene therapy facility in Baltimore.Some support1 report
No events began in the chosen period. Widen it, or reset.
History
Events by the month they beganJune 2026
2 events- Silexion Therapeutics Corp. pioneers RNAi therapies for KRAS-driven cancers, establishing partnerships with AMS and Catalent.
- The FDA accepted a revised approval submission regarding a Biohaven drug, while simultaneously canceling advisory committee discussions. This occurred amidst corporate restructuring, including Novo Holdings acquiring Catalent, which has a gene therapy facility in Baltimore.